07 04 2026
In the 2025 Annual Report Skal Biocontrole reflects on a year in which the organization further strengthened its implementation capacity. In 2025 new statutory tasks were set up on time, significant steps were taken in digitalisation and housing, and supervision of compliance was further reinforced.
2025 was characterised by cooperation and consolidation: for the third consecutive year Skal executed all statutory tasks in full and expanded its portfolio with a substantial new responsibility in the control of import consignments. At the same time, Skal invested in people, systems and premises to remain sufficiently agile and robust in 2026 and beyond.
Highlights 2025
- Import control transferred from Customs: as of 1 March 2025 Skal is responsible for all document checks (D‑checks) on biological import consignments. From September 2025 Skal also conducts random conformity checks (O‑checks); in 2025, 50 O‑checks were performed, with no deviations identified.
- Statutory supervision tasks carried out: in 2025 Skal performed, among others, 592 additional risk‑based inspections (11 % of certified companies), 717 unannounced inspections (10.5 % of 6,799 official controls) and 350 sampling events at 311 locations (5.8 % of the number of companies).
- Higher compliance among certified companies: no non‑conformities were found in 76.6 % of certified companies (2024: 72 %). The number of critical deviations (NC‑A) also continued to decline.
- Strengthening chain management and cooperation: Skal further refined its role in the import‑control chain and worked intensively with chain partners.